Drug intelligence / Profile preview

estradiol benzoate + prednisolone + salicylic acid

Development stage
Unknown
Lead developer
Dr August Wolff
Modality
Small Molecules
Administration
Topical
01

Overview

Alpicort F is a topical prescription solution developed by Dr. August Wolff GmbH & Co. KG for the treatment of inflammatory scalp conditions and hormonal-hereditary hair loss (androgenetic alopecia) in women. It is a fixed-dose combination product containing estradiol benzoate, prednisolone, and salicylic acid. Estradiol benzoate, an estrogen, promotes hair growth and inhibits the formation of dihydrotestosterone (DHT). Prednisolone is a glucocorticoid that provides anti-inflammatory and immunosuppressive effects. Salicylic acid acts as a keratolytic and anti-inflammatory agent, facilitating the penetration of the other active ingredients. The product is currently being evaluated in Phase III clinical trials for its efficacy in promoting hair density recovery in women following chemotherapy-induced alopecia.

Brand names
Alpicort FAlpicort® F
02

Targets

ESR1 (ERα)ESR2 (ERβ)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on estradiol benzoate + prednisolone + salicylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estradiol benzoate + prednisolone + salicylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call